Klebsiella pneumoniae infections after liver transplantation: Drug resistance and distribution of pathogens, risk factors, and influence on outcomes
- PMID: 38689752
- PMCID: PMC11056902
- DOI: 10.4254/wjh.v16.i4.612
Klebsiella pneumoniae infections after liver transplantation: Drug resistance and distribution of pathogens, risk factors, and influence on outcomes
Abstract
Background: Liver transplantation (LT) is the only curative treatment for end-stage liver disease. However, LT recipients are susceptible to infection, which is the leading cause of early mortality after LT. Klebsiella pneumoniae infections (KPIs) in the bloodstream are common in LT recipients. We hypothesized that KPIs and carbapenem-resistant Klebsiella pneumoniae (CRKP) infections may affect the outcomes of LT recipients.
Aim: To assess KPI incidence, timing, distribution, drug resistance, and risk factors following LT and its association with outcomes.
Methods: This retrospective study included 406 patients undergoing LT at The Third Xiangya Hospital of Central South University, a tertiary hospital, from January 2015 to January 2023. We investigated the risk factors for KPIs and assessed the impact of KPIs and CRKP infections on the prognosis of LT recipients using logistic regression analysis.
Results: KPI incidence was 7.9% (n = 32), with lung/thoracic cavity the most frequent site of infection; the median time from LT to KPI onset was 7.5 d. Of 44 Klebsiella pneumoniae isolates, 43 (97.7%) and 34 (77.3%) were susceptible to polymyxin B or ceftazidime/avibactam and tigecycline, respectively; > 70% were resistant to piperacillin/ tazobactam, ceftazidime, cefepime, aztreonam, meropenem, and levofloxacin. Female sex [odds ratio (OR) = 2.827, 95% confidence interval (CI): 1.256-6.364; P = 0.012], pre-LT diabetes (OR = 2.794, 95%CI: 1.070-7.294; P = 0.036), day 1 post-LT alanine aminotransferase (ALT) levels ≥ 1500 U/L (OR = 3.645, 95%CI: 1.671-7.950; P = 0.001), and post-LT urethral catheter duration over 4 d (OR = 2.266, 95%CI: 1.016-5.054; P = 0.046) were risk factors for KPI. CRKP infections, but not KPIs, were risk factors for 6-month all-cause mortality post-LT.
Conclusion: KPIs occur frequently and rapidly after LT. Risk factors include female sex, pre-LT diabetes, increased post-LT ALT levels, and urethral catheter duration. CRKP infections, and not KPIs, affect mortality.
Keywords: Carbapenem-resistant Klebsiella pneumoniae; Klebsiella pneumoniae infections; Liver transplantation; Outcomes; Risk factors.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All the Authors have no conflict of interest related to the manuscript.
Similar articles
-
Carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation: Drug resistance, risk factors and impact on prognosis.World J Gastroenterol. 2025 Feb 28;31(8):98415. doi: 10.3748/wjg.v31.i8.98415. World J Gastroenterol. 2025. PMID: 40062326 Free PMC article.
-
Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients.Liver Transpl. 2015 Dec;21(12):1511-9. doi: 10.1002/lt.24207. Liver Transpl. 2015. PMID: 26136397 Free PMC article.
-
Epidemic, risk factors of carbapenem-resistant Klebsiella pneumoniae infection and its effect on the early prognosis of liver transplantation.Front Cell Infect Microbiol. 2022 Oct 6;12:976408. doi: 10.3389/fcimb.2022.976408. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36275019 Free PMC article.
-
Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: a systematic review and meta-analysis.Antimicrob Resist Infect Control. 2020 Jan 31;9(1):23. doi: 10.1186/s13756-020-0686-0. Antimicrob Resist Infect Control. 2020. PMID: 32005246 Free PMC article.
-
Relationship between antibiotic exposure and carbapenem-resistant Klebsiella pneumoniae infection within four types of control patients: A systematic review and meta-analysis.J Glob Antimicrob Resist. 2023 Jun;33:137-151. doi: 10.1016/j.jgar.2023.02.020. Epub 2023 Mar 10. J Glob Antimicrob Resist. 2023. PMID: 36906174
Cited by
-
Clinical Application of Metagenomic Next-Generation Sequencing (mNGS) in Patients with Early Pulmonary Infection After Liver Transplantation.Infect Drug Resist. 2024 Dec 19;17:5685-5698. doi: 10.2147/IDR.S483684. eCollection 2024. Infect Drug Resist. 2024. PMID: 39717063 Free PMC article.
-
Challenges of Klebsiella pneumoniae infections post-liver transplantation: Insights and future directions.World J Hepatol. 2025 Jul 27;17(7):107213. doi: 10.4254/wjh.v17.i7.107213. World J Hepatol. 2025. PMID: 40747225 Free PMC article.
References
-
- Kim WR, Lake JR, Smith JM, Skeans MA, Schladt DP, Edwards EB, Harper AM, Wainright JL, Snyder JJ, Israni AK, Kasiske BL. OPTN/SRTR 2013 Annual Data Report: liver. Am J Transplant. 2015;15 Suppl 2:1–28. - PubMed
-
- Cervera C, van Delden C, Gavaldà J, Welte T, Akova M, Carratalà J ESCMID Study Group for Infections in Compromised Hosts. Multidrug-resistant bacteria in solid organ transplant recipients. Clin Microbiol Infect. 2014;20 Suppl 7:49–73. - PubMed
-
- Linares L, Cervera C, Hoyo I, Sanclemente G, Marco F, Cofán F, Ricart MJ, Navasa M, Moreno A. Klebsiella pneumoniae infection in solid organ transplant recipients: epidemiology and antibiotic resistance. Transplant Proc. 2010;42:2941–2943. - PubMed
LinkOut - more resources
Full Text Sources